JAMA study examines postpartum GLP-1 initiation among insured US women
The cross-sectional analysis looks at how often commercially insured women start GLP-1 receptor agonists after giving birth.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 30 20:00 ETSource: JAMA
The wire
- 01A cross-sectional study in JAMA examines rates of GLP-1 receptor agonist initiation among commercially insured women in the United States during the postpartum period.
- 02Postpartum prescribing patterns matter for clinicians weighing lactation, contraception and weight management counseling after delivery.
- 03The published summary does not report initiation rates or cohort size, and commercial claims data exclude Medicaid and uninsured populations.
From the source
Read at pubmed.ncbi.nlm.nih.govPostpartum Initiation of GLP-1 Receptor Agonists Among Commercially Insured Women in the US
JAMA · 2026 Oct 1 · Cai ST, Simon K, Shanks AL et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42821286/
